Stock Events

Arrowhead Pharmaceuticals (A2RR34.SA) Q3 2023 Earnings

7AugConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-4.7
-2.38
-0.06
2.27

Details

Expected EPS
-3.57627
Actual EPS
-4.70304
Surprise EPS
-1.13
Surprise Percent
+31.51%

Description

Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -4.70304 per share for Q3 2023.

0 Comments

Share your thoughts